Q4 2024 Biogaia AB Earnings Call Transcript

Author's Avatar
Feb 12, 2025

Feb 12, 2025 / 08:30AM GMT
Operator

Welcome to Biogaia Q4 report for 2024.

(Operator Instructions)

Now I will hand the conference over to CEO, Theresa Agnew, and CFO, Alexander Kotsinas. Please go ahead.

Theresa Agnew - Biogaia AB - Chief Executive Officer, President

Hi, this is Theresa Agnew, CEO of Biogaia. We're here to present our Q4 results.

As an overall, executive summary for the quarter, our sales were SEK365 million, which is growth of 23%, and excluding currency effects, that's growth of 24%. Sales in Europe, Middle East, Africa increased by 24%, in Asia Pacific by 10%, and in the Americas by 32% for the quarter.

Our EBIT was SEK103 million, which is growth of 28%, and our margin of 28% for the quarter. If you look at the total year, the total year for 2024, we had sales of approximately SEK1.4 billion, which is growth of 10%.

We had an EBIT margin of 30%, adjusted EBIT margin of 34%, which is without the MetaboGen impairment loss and if you look at the regions for the total of 2024, Europe, Middle East, Africa grew 3%, Asia Pacific grew

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot